Capstone Investment Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-300
Closed -$21.6K – 1846
2024
Q4
$21.6K Hold
300
– – ﹤0.01% 1793
2024
Q3
$24K Buy
+300
New +$22.5K ﹤0.01% 1848
2024
Q2
– Sell
-200
Closed -$14.1K – 2464
2024
Q1
$14.1K Buy
+200
New +$14.3K ﹤0.01% 2279
2023
Q4
– Sell
-600
Closed -$40.8K – 2398
2023
Q3
$40.8K Hold
600
– – ﹤0.01% 2032
2023
Q2
$49K Buy
+600
New +$48.2K ﹤0.01% 1766
2022
Q2
– Sell
-3,200
Closed -$346K – 2109
2022
Q1
$346K Buy
+3,200
New +$330K ﹤0.01% 1566
2021
Q4
– Sell
-3,600
Closed -$436K – 2084
2021
Q3
$436K Buy
+3,600
New +$438K ﹤0.01% 1591

Other funds holding TECH

Capstone Investment Advisors's TECH Position: Q2 2026 in Review

Capstone Investment Advisors opened a new position in Bio-Techne (TECH) in Q2 2026: 210,000 shares worth $14.8M. The stake represents 0.03% of the portfolio and ranks #262 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in TECH as recently as Q3 2025.

Capstone Investment Advisors first reported a position in TECH in Q4 2016 and has held it in 10 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Capstone Investment Advisors held 210,000 shares of Bio-Techne worth $14.8M as of Q2 2026.
  • Bio-Techne was a new Capstone Investment Advisors position in Q2 2026.
  • Bio-Techne made up 0.03% of Capstone Investment Advisors's portfolio in Q2 2026, its #262 holding.
  • Capstone Investment Advisors first reported a position in Bio-Techne in Q4 2016 and has held it in 10 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.